AI creates for the first time an experimental treatment for a disease forgotten by pharmaceutical companies
The laboratory of the latest Nobel Prize winner in Chemistry David Baker, headed by researcher Susana Vázquez, talks about ‘democratizing’ the discovery of therapies
David Baker, winner of the latest Nobel Prize in Chemistry, claims that humanity is undergoing a transformation as momentous as learning to handle metals at the end of the Stone Age. He speaks of “the protein design revolution,” comparable to the Industrial Revolution, which changed the planet with its steam engines. His laboratory at the University of Washington announced on Wednesday that its disruptive artificial intelligence programs, for which Baker won the Nobel Prize, have succeeded for the first time in creating a treatment for a disease forgotten by big pharmaceutical companies. At the forefront of this scientific feat is the Mexican biochemist Susana Vázquez, who has just left the United States to join the National Cancer Research Center in Madrid, Spain.
